Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > NEWS: Claritas Announces Settlement of Debt Transaction
View:
Post by Amazigh on Apr 07, 2021 5:11pm

NEWS: Claritas Announces Settlement of Debt Transaction

Claritas Announces Settlement of Debt Transaction SAN FRANCISCO, CA and TORONTO, ON -- (April 7, 2021) Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Claritas") today announced that it has entered into an agreement to pay amounts owing to a service provider for past services in common shares of the Company (Common Shares). The transaction is subject to approval by the TSX Venture Exchange (the TSXV). The debt owing is in the amount of USD $35,000 (or CAD $43,825.25 based on the daily average exchange rate for April 7, 2021 published by the Bank of Canada). This debt (the Debt) is owed to Cova Capital Partners, LLC (Cova), and is the cash commission that the Company agreed to pay to Cova for broker services provided by Cova relating to the Companys previously announced private placement of common shares and common share purchase warrants on September 16, 2019. The Company will issue to Cova 973,894 common shares, based on the deemed share price of $0.045. The Company will issue these Common Shares upon approval of the TSXV.
Comment by ETalien on Apr 07, 2021 5:27pm
Getting the ducks lined up for the biggie! :)
Comment by Moonshiner592 on Apr 07, 2021 5:29pm
You bet!  We should be seeing some green next week or so.... I can't wait!!!
Comment by ETalien on Apr 07, 2021 5:32pm
I think Claritas will be a household name... :)
Comment by polygraph46 on Apr 08, 2021 12:18am
Earth to Alien: Re: Claritas will become a household name. Are you thinking what I'm thinking ..something like  Sani-flush?
Comment by ETalien on Apr 08, 2021 8:12am
Hey losingmyshirt, are you running low on the product you use on your day job? Can i hire you, my toilet needs a good cleaning and I know you can do a wonderful job shining up that bowl! What do you say?  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities